The 75 mg Venlor tablet typically bears the imprint “V 75” or a similar manufacturer-specific code. The exact lettering can vary by batch, so checking the packaging or consulting a pharmacist confirms authenticity.
Patients may notice improvements in mood or anxiety within 1-2 weeks, but the full therapeutic effect often requires 4-6 weeks of consistent use.
Venlafaxine is not a controlled substance and does not trigger standard illicit-drug screening panels. However, specialized tests can detect prescription antidepressants if specifically requested.
Yes, provided you carry the medication in its original labelled container, keep it in your carry-on luggage, and have a copy of the prescription. Some countries may require a doctor’s note, so check local regulations before departure.
Many OTC sleep aids contain antihistamines (e.g., diphenhydramine) which can increase sedation when combined with venlafaxine. Discuss any sleep aids with your healthcare provider to avoid excessive drowsiness.
Maintain the medication at room temperature, away from direct heat sources. If temperatures exceed 30 °C for an extended period, store the pill in a cool, dry place such as a refrigerator (not frozen) to preserve potency.
Venlor is marketed under a specific brand name but contains the same active ingredient, venlafaxine, as generic versions. Differences may lie in inactive excipients, pill appearance, or manufacturer pricing.
Occasional light alcohol consumption is not contraindicated, but excessive drinking can intensify side effects like dizziness and should be avoided.
“Brain zaps” are a common description of electric-shock-like sensations that can occur during venlafaxine tapering. They reflect withdrawal effects and are usually mitigated by a gradual dose reduction under medical supervision.
Venlor contains the active ingredient venlafaxine, an antidepressant belonging to the class of serotonin-norepinephrine reuptake inhibitors (SNRIs). It is supplied as a 75 mg pill and is prescribed by a qualified healthcare professional in Hong Kong. Venlafaxine is approved for prescription use (Rx) and is regulated by the Hong Kong Pharmacy and Poisons Board, which follows international standards for safety and efficacy.
Venlafaxine influences mood by blocking the reuptake of two key neurotransmitters - serotonin and norepinephrine - thereby increasing their levels in the synaptic cleft. The drug’s effect on serotonin occurs at lower doses, while higher concentrations also inhibit norepinephrine reuptake, providing a broader antidepressant action.
Venlafaxine is FDA- and EMA-approved for the following indications, which are also recognised by Hong Kong regulators:
These conditions are typically managed in adults, and treatment decisions consider disease severity, previous therapy response, and individual health status.
Research and clinical guidelines have explored additional applications of venlafaxine. When used outside formal approval, the medication must be prescribed with careful risk-benefit assessment.
Off-label use requires medical supervision and individualized risk assessment.
These reactions are usually mild to moderate and often improve within the first few weeks.
Patients should disclose all prescription medicines, over-the-counter products, supplements, and herbal remedies to their healthcare provider before initiating Venlor.
This article provides educational information about Venlor and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
